Health meets simplicity'span>
Welldoc’s AI-driven platform delivers personalized, actionable insights, empowering individuals and their care teams to achieve better health outcomes.
Address multiple conditions
Type 1 and Type 2 Diabetes
Hypertension
Heart Failure
Weight & GLP-1 Support
Prediabetes
Mental Wellbeing & Sleep
Unlock better health
Hightlights from our research findings:
A1C
Improvement*1
Blood Pressure
Reduction*2
Cost Savings Per Person
with Diabetes*3

in 6 months
Based on individuals who
added weight data*4
1. Quinn, C.C. Shardell, M.D. Terrin, M.L. Barr, E.A. Ballew, S.H. Gruber-Baldini, A.L. Cluster-randomized trial of a mobile phone personalized behavioral intervention for blood glucose control. Diabetes Care. 2011 Sep;34(9):1934-42. Erratum in: Diabetes Care. 2013 Nov;36(11):3850.
2. Kumbara A, Iyer A, Shomali M. Blood pressure improvement in people using a digital health solution for comprehensive diabetes self-management. Poster presented at: 16th Annual Cardiometabolic Health Congress; October 14-17, 2021; National Harbor, MD.
3. IBM Watson Health. Estimating the economic value of a digital therapeutic in type 2 diabetes. Welldoc-sponsored report 2018. Published August 2018.
4. Welldoc Data on File. Subset of multiple Welldoc programs (n = 106 who paired with weight scales/data). 68% of 106 experienced an average of 6% weight loss over a duration of 6 months. ​Results may vary based on Welldoc App adherence​.
Lead with
evidence-based care
Clearances*
Anytime, anywhere chronic care
Empower people everywhere to self-manage their chronic conditions.
Enable health ecosystems to optimize interventions, clinical decisions and population health.
Total Care
An AI-powered digital coaching app, to encourage the self-management of cardiometabolic conditions, positive lifestyle changes and better total health
CONNECTED CARE
Data-driven insights to support care team interventions, decision making, and population level health and cost outcomes
EVIDENCE-BASED CARE
Guidance and insights based on clinical standards, with FDA-cleared capabilities for type 1 and type 2 diabetes*
CARE ANYWHERE
Scalable solution to securely connect health data from 400+ devices and data solutions, while integrating with existing care workflows
Featured Partners
Together, we can transform chronic care
Industry Recognition
The Latest
Hear from our users
BlueStar is Welldoc’s FDA-Cleared solution for Type 1 and Type 2 diabetes, and is now part of the Welldoc platform
“I’m not a super tech-savvy person, but using BlueStar is very easy.”
“It’s very beneficial in managing my diabetes and in working with my doctor as a team to manage my diabetes.”
“I owe that success in my life in controlling diabetes because of my physicians, and in a large part because of this program called BlueStar.”
“I like the different lessons because they help me to get a better understanding of what I can and can’t eat.”
“I really like that I can record my blood glucose, blood pressure, weight, and medications.”
“I can just open BlueStar up and record everything right away. It’s just easy and I like that.”
We’re here to help
every step of the way
*Welldoc® Diabetes and Welldoc Diabetes Rx is an FDA-cleared medical device, intended for use by healthcare providers and their adult patients with type 1 or type 2 diabetes. The other Welldoc App products are non-FDA-cleared and intended to promote general wellness and education/self-management of various chronic disease states.Â
1. Quinn, C.C. Shardell, M.D. Terrin, M.L. Barr, E.A. Ballew, S.H. Gruber-Baldini, A.L. Cluster-randomized trial of a mobile phone personalized behavioral intervention for blood glucose control. Diabetes Care. 2011 Sep;34(9):1934-42. Erratum in: Diabetes Care. 2013 Nov;36(11):3850.
2. Kumbara A, Iyer A, Shomali M. Blood pressure improvement in people using a digital health solution for comprehensive diabetes self-management. Poster presented at: 16th Annual Cardiometabolic Health Congress; October 14-17, 2021; National Harbor, MD.
3. IBM Watson Health. Estimating the economic value of a digital therapeutic in type 2 diabetes. Welldoc-sponsored report 2018. Published August 2018.
4. Welldoc Data on File. Subset of multiple Welldoc programs (n = 106 who paired with weight scales/data). 68% of 106 experienced an average of 6% weight loss over a duration of 6 months. ​Results may vary based on Welldoc App adherence​.
“It’s very beneficial in managing my diabetes and in working with my doctor as a team to manage my diabetes.”